AWP
CME icon

Accretive Wealth Partners’s CME Group CME Stock Holding History

Accretive Wealth Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Buy
8,067
+16
+0.2% +$4.75K 0.67% 41
2025
Q4 		$2.2M Buy
8,051
+409
+5% +$111K 0.65% 45
2025
Q3 		$2.06M Buy
7,642
+149
+2% +$40.5K 0.63% 50
2025
Q2 		$2.07M Buy
7,493
+90
+1% +$24.5K 0.68% 48
2025
Q1 		$2.1M Buy
7,403
+723
+11% +$178K 0.74% 40
2024
Q4 		$1.55M Sell
6,680
-26
-0.4% -$5.98K 0.66% 51
2024
Q3 		$1.48M Sell
6,706
-59
-0.9% -$12.2K 0.62% 56
2024
Q2 		$1.33M Buy
6,765
+61
+0.9% +$12.6K 0.56% 60
2024
Q1 		$1.39M Buy
6,704
+54
+0.8% +$11.3K 0.62% 54
2023
Q4 		$1.4M Sell
6,650
-3
-0% -$640 0.67% 55
2023
Q3 		$1.33M Buy
6,653
+76
+1% +$15.1K 0.79% 37
2023
Q2 		$1.22M Buy
6,577
+129
+2% +$23.8K 0.72% 46
2023
Q1 		$1.23M Buy
6,448
+271
+4% +$49K 0.79% 42
2022
Q4 		$1.04M Buy
6,177
+259
+4% +$45K 0.71% 47
2022
Q3 		$1.05M Buy
5,918
+16
+0.3% +$3.16K 0.8% 41
2022
Q2 		$1.21M Buy
5,902
+144
+3% +$30.5K 0.88% 37
2022
Q1 		$1.37M Buy
5,758
+188
+3% +$44.2K 0.86% 38
2021
Q4 		$1.27M Buy
5,570
+220
+4% +$48.4K 0.81% 43
2021
Q3 		$1.03M Buy
5,350
+285
+6% +$57.7K 0.73% 56
2021
Q2 		$1.08M Buy
5,065
+604
+14% +$128K 0.78% 52
2021
Q1 		$911K Buy
4,461
+309
+7% +$60.9K 0.82% 50
2020
Q4 		$756K Buy
+4,152
New +$706K 0.75% 54

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Accretive Wealth Partners's CME Position: Q1 2026 in Review

Accretive Wealth Partners increased its CME Group (CME) stake by 0.2% in Q1 2026, buying an estimated $4.75K and bringing the position to 8,067 shares worth $2.38M. The position accounts for 0.67% of the portfolio, ranked #41.

Accretive Wealth Partners first reported a position in CME in Q4 2020 and has held it in 22 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Accretive Wealth Partners held 8,067 shares of CME Group worth $2.38M as of Q1 2026.
  • Accretive Wealth Partners bought 16 CME Group shares in Q1 2026, an estimated $4.75K.
  • CME Group made up 0.67% of Accretive Wealth Partners's portfolio in Q1 2026, its #41 holding.
  • Accretive Wealth Partners first reported a position in CME Group in Q4 2020 and has held it in 22 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Accretive Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.